Navigation Links
Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
Date:5/10/2011

she's undergoing treatment.

"Amgen is passionate about helping those with cancer, and we are proud to honor individuals who have made a positive difference in the fight against cancer," said Stuart Arbuckle, vice president and general manager, Amgen Oncology. "Breakaway from Cancer was founded on the knowledge that it takes a team to overcome this disease and the Champions program exemplifies this commitment to helping others."

Founded by Amgen in 2005, Breakaway from Cancer raises awareness of the important resources available to people impacted by cancer – from prevention through survivorship. Breakaway from Cancer represents a collaboration between Amgen and four nonprofit organizations dedicated to empowering patients with education, resources, and hope.

The Breakaway from Cancer Champions will lead the Breakaway Mile, an approximately one-mile walk to celebrate cancer survivors that crosses the Amgen Tour of California finish line prior to the stage conclusion of the professional race. The Breakaway Mile will take place in five 2011 race host cities: North Lake Tahoe, Sacramento, Modesto, Paso Robles, and Thousand Oaks.  Each Breakaway Mile will also feature an Amgen scientist who plays a crucial role in developing breakthrough medicines.

At the conclusion of each stage of the Amgen Tour of California, the Breakaway from Cancer Champion or a local cancer survivor will present Amgen's Breakaway from Cancer Most Courageous Rider jersey to the professional rider who best exemplifies the character of those engaged in the fight against cancer—courage, sacrifice, inspiration, determination, and perseverance.

During the 2011 Amgen Tour of California, a local cancer survivor will officially start each day's stage by firing the official start gun. He or she will also have the opportunity to meet the prior day's recipient of Amgen's Breakaway from Cancer Most
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Californians Help Produce As Well As Benefit from Lifesaving Therapies
2. GenerationOne Selected by Cincinnati Childrens Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics
3. ZINO Society Fund Investors Selected VacuPractor
4. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
5. Digital Assent CEO Selected as Finalist for 2011 Southeast Entrepreneur Awards
6. e-MDs Selected by Medical Society of the State of New York
7. FHI Selected as Preferred Provider to a Consortium of Product Development Partnerships
8. Dynatronics Selected for Inclusion in RB Milestone Portfolio
9. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
10. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
11. BioSurplus Selected to Liquidate Discovery Laboratory Equipment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  An International Trade Commission (ITC) ruling issued Friday ... device, Taiwanese device manufacturer APEX continues to infringe ResMed ... ) is the innovation leader and pioneer in designing ... "Our research and development teams are ... of comfort, performance and efficacy," said David Pendarvis ...
(Date:7/21/2014)... Apex Medical Corporation (Apex, TWSE: 4106), a leading player ... announces that the United States International Trade Commission (USITC) ... newly designed XT series continuous positive airway pressure (CPAP) ... the patent claims asserted by ResMed, one of Apex,s ... an upgraded iCH water tank to the market in ...
(Date:7/18/2014)... 2014 Hanger, Inc. (NYSE: HGR ) ... operations for the quarter ended June 30, 2014, on Tuesday, ... to discuss these results is scheduled to begin at 9:00 ... participate should call 1-877-662-6095. A replay will be available until ... ID # 44683027. About Hanger, Inc. – Built ...
Breaking Medicine Technology:ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2Apex Medical's Respiratory Therapy Product Receives Affirmation from USITC 2
... an international generic pharmaceuticals company, today announced that ... Food & Drug Administration to market Zolpidem Tartrate ... the product has commenced.   Actavis ... Extended-Release Tablets 6.25 mg strength in October 2010 with ...
... 6, 2011 Pharmacyclics, Inc. (Nasdaq: PCYC ... the Phase IB/II study of the Btk inhibitor, PCI-32765, ... (CLL/SLL) at the 2011 American Society of Clinical Oncology ... development program update for the Btk Inhibitor, PCI-32765.  The ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 3Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 4Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 5Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 6Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 7Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 8Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 9
(Date:7/21/2014)... iFitDress.com, a famous company of wedding dresses and special ... of 2014 glitter evening dresses . Moreover, the ... gowns. , iFitDress.com is one of the most loved ... in the recent years, not just because of its ... amicable services offered on its website. , The ...
(Date:7/21/2014)... MA (PRWEB) July 21, 2014 What ... extramarital affair have in common? You can find them ... Heart! The novel's main character, Miranda, lives on Martha’s ... meets Clay, a wealthy New Yorker, and becomes entangled ... of the Heart challenges readers to think about what ...
(Date:7/21/2014)... July 21, 2014 Executives from ... specializing in private healthcare practices, will participate in ... They will be showcasing their state-of-the-art capabilities and ... practices all over the United States as the ... continues to increase. Advice Media’s presence at IACA ...
(Date:7/21/2014)... 2014The Associated Press-NORC Center for Public Affairs Research has ... public,s opinions about what it means to be a ... survey, funded by the Robert Wood Johnson Foundation, sheds ... of their health care and doctors, as well as ... care decisions. The survey produces new and actionable data ...
(Date:7/21/2014)... 2014 (HealthDay News) -- Good parenting and life ... from low-income families, a new study suggests. ... and can lead to a number of illnesses, ... problems in both childhood and adulthood involve excessive ... heart disease, allergies and some cancers," study author ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: 2014 Glitter Evening Dresses For Worldwide Clients 2Health News:Thea Marsh Releases Debut Novel that Celebrates and Reaches out to Women Everywhere 2Health News:Advice Media to Attend the International Association of Comprehensive Aesthetics Conference (IACA) Targeting the Dental Profession 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2Health News:Life Skills, Parenting Classes May Cut Inflammation in Poor Kids 2
... past have argued about the implications of Hormone Replacement Therapy ... A new study, however, has gone further to show that ... developing breast cancer// if they consumed alcoholic beverages. ,The ... pattern and on whether they were on HRT currently or ...
... have found that people who take anti-depressants to relieve ... developing gastrointestinal bleeding. The study which was conducted over ... were compared for hospitalizations due to upper GI bleeding ... on selective serotonin reuptake inhibitors, or SSRIs, were 3.6-times ...
... by a Diabetes Research Centre in India has shown that ... had considerable improvement when they followed safe practices advised by ... doctors discovering that many patients came to the Centre with ... their lives. They decided that a little change in lifestyle ...
... called 'HERS' conducted by researchers of the University of California, ... that Hormone Replacement Therapy (HRT) may be able to reduce ... develop diabetes as well. ,The study involved some women ... had "impaired fasting glucose" - a condition with some ...
... 61 previous studies of blood pressure and cardiovascular disease, which ... regardless of age and even if readings are in the ... reducing risk of strokes and heart attacks. ,The study ... that out of the 120,000 who died, 56,000 suffered fatal ...
... Chairman and Managing Director of Eli Lilly and Co., India, ... cut in the company's human insulin product 'Huminsulin', that its ... market by the end of this year. He added that ... use of human insulin products and the phasing out of ...
Cached Medicine News:Health News:Women on HRT should avoid alcohol 2
... a multipurpose agarose, has been developed for ... and separation of high molecular weight DNA ... a high gel strength agarose ( 1800 ... the use of low concentrations of agarose ...
Inquire...
... Agarose is a premium agarose used for ... This agarose produces clear sharp bands, with ... lot of UltraClean Forensic Agarose is tested ... activity, RNase activity and DNA contamination. ...
... specifically formulated for high resolution of small ... This standard melting temperature agarose can resolve ... bp difference in size. UltraPure™ Agarose ... for better handling and improved clarity for ...
Medicine Products: